Browsing Tag
diabetes technology
3 posts
A $560m test for the diabetes device market as MiniMed prepares to trade on Nasdaq
MiniMed prices its IPO at $20 per share, raising $560M as Medtronic plc spins out its diabetes unit. Discover what the move means for the diabetes technology market.
From Medtronic to the market: What MiniMed’s IPO means for CGM and insulin pump competition
Medtronic files IPO for MiniMed, its diabetes device business. Find out what this spin-off could mean for the future of CGM and insulin delivery tech.
Tandem Diabetes Care wins FDA clearance to bring its Tandem Mobi insulin pump app to Android users
Find out how Tandem Diabetes Care’s FDA clearance for its Android app expands insulin pump access and reshapes the diabetes tech market.